purchase customization

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neurology Clinical Trial
1.2 Key Market Segments
1.2.1 Neurology Clinical Trial Segment by Type
1.2.2 Neurology Clinical Trial Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurology Clinical Trial Market Overview
2.1 Global Market Overview
2.1.1 Global Neurology Clinical Trial Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurology Clinical Trial Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurology Clinical Trial Market Competitive Landscape
3.1 Global Neurology Clinical Trial Sales by Manufacturers (2019-2024)
3.2 Global Neurology Clinical Trial Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurology Clinical Trial Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurology Clinical Trial Sales Sites, Area Served, Product Type
3.6 Neurology Clinical Trial Market Competitive Situation and Trends
3.6.1 Neurology Clinical Trial Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurology Clinical Trial Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neurology Clinical Trial Industry Chain Analysis
4.1 Neurology Clinical Trial Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neurology Clinical Trial Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neurology Clinical Trial Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurology Clinical Trial Sales Market Share by Type (2019-2024)
6.3 Global Neurology Clinical Trial Market Size Market Share by Type (2019-2024)
6.4 Global Neurology Clinical Trial Price by Type (2019-2024)
7 Neurology Clinical Trial Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurology Clinical Trial Market Sales by Application (2019-2024)
7.3 Global Neurology Clinical Trial Market Size (M USD) by Application (2019-2024)
7.4 Global Neurology Clinical Trial Sales Growth Rate by Application (2019-2024)
8 Neurology Clinical Trial Market Segmentation by Region
8.1 Global Neurology Clinical Trial Sales by Region
8.1.1 Global Neurology Clinical Trial Sales by Region
8.1.2 Global Neurology Clinical Trial Sales Market Share by Region
8.2 North America
8.2.1 North America Neurology Clinical Trial Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurology Clinical Trial Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurology Clinical Trial Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurology Clinical Trial Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurology Clinical Trial Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 BrainStorm Cell Therapeutics
9.1.1 BrainStorm Cell Therapeutics Neurology Clinical Trial Basic Information
9.1.2 BrainStorm Cell Therapeutics Neurology Clinical Trial Product Overview
9.1.3 BrainStorm Cell Therapeutics Neurology Clinical Trial Product Market Performance
9.1.4 BrainStorm Cell Therapeutics Business Overview
9.1.5 BrainStorm Cell Therapeutics Neurology Clinical Trial SWOT Analysis
9.1.6 BrainStorm Cell Therapeutics Recent Developments
9.2 Opexa Therapeutics
9.2.1 Opexa Therapeutics Neurology Clinical Trial Basic Information
9.2.2 Opexa Therapeutics Neurology Clinical Trial Product Overview
9.2.3 Opexa Therapeutics Neurology Clinical Trial Product Market Performance
9.2.4 Opexa Therapeutics Business Overview
9.2.5 Opexa Therapeutics Neurology Clinical Trial SWOT Analysis
9.2.6 Opexa Therapeutics Recent Developments
9.3 Caladrius Biosciences
9.3.1 Caladrius Biosciences Neurology Clinical Trial Basic Information
9.3.2 Caladrius Biosciences Neurology Clinical Trial Product Overview
9.3.3 Caladrius Biosciences Neurology Clinical Trial Product Market Performance
9.3.4 Caladrius Biosciences Neurology Clinical Trial SWOT Analysis
9.3.5 Caladrius Biosciences Business Overview
9.3.6 Caladrius Biosciences Recent Developments
9.4 U.S. Stem Cell
9.4.1 U.S. Stem Cell Neurology Clinical Trial Basic Information
9.4.2 U.S. Stem Cell Neurology Clinical Trial Product Overview
9.4.3 U.S. Stem Cell Neurology Clinical Trial Product Market Performance
9.4.4 U.S. Stem Cell Business Overview
9.4.5 U.S. Stem Cell Recent Developments
9.5 Lonza
9.5.1 Lonza Neurology Clinical Trial Basic Information
9.5.2 Lonza Neurology Clinical Trial Product Overview
9.5.3 Lonza Neurology Clinical Trial Product Market Performance
9.5.4 Lonza Business Overview
9.5.5 Lonza Recent Developments
9.6 Bristol Myers Squibb
9.6.1 Bristol Myers Squibb Neurology Clinical Trial Basic Information
9.6.2 Bristol Myers Squibb Neurology Clinical Trial Product Overview
9.6.3 Bristol Myers Squibb Neurology Clinical Trial Product Market Performance
9.6.4 Bristol Myers Squibb Business Overview
9.6.5 Bristol Myers Squibb Recent Developments
9.7 Corning Incorporated
9.7.1 Corning Incorporated Neurology Clinical Trial Basic Information
9.7.2 Corning Incorporated Neurology Clinical Trial Product Overview
9.7.3 Corning Incorporated Neurology Clinical Trial Product Market Performance
9.7.4 Corning Incorporated Business Overview
9.7.5 Corning Incorporated Recent Developments
9.8 Vericel Corporation
9.8.1 Vericel Corporation Neurology Clinical Trial Basic Information
9.8.2 Vericel Corporation Neurology Clinical Trial Product Overview
9.8.3 Vericel Corporation Neurology Clinical Trial Product Market Performance
9.8.4 Vericel Corporation Business Overview
9.8.5 Vericel Corporation Recent Developments
9.9 Catalent
9.9.1 Catalent Neurology Clinical Trial Basic Information
9.9.2 Catalent Neurology Clinical Trial Product Overview
9.9.3 Catalent Neurology Clinical Trial Product Market Performance
9.9.4 Catalent Business Overview
9.9.5 Catalent Recent Developments
9.10 Lineage Cell Therapeutics
9.10.1 Lineage Cell Therapeutics Neurology Clinical Trial Basic Information
9.10.2 Lineage Cell Therapeutics Neurology Clinical Trial Product Overview
9.10.3 Lineage Cell Therapeutics Neurology Clinical Trial Product Market Performance
9.10.4 Lineage Cell Therapeutics Business Overview
9.10.5 Lineage Cell Therapeutics Recent Developments
9.11 Castle Creek Biosciences
9.11.1 Castle Creek Biosciences Neurology Clinical Trial Basic Information
9.11.2 Castle Creek Biosciences Neurology Clinical Trial Product Overview
9.11.3 Castle Creek Biosciences Neurology Clinical Trial Product Market Performance
9.11.4 Castle Creek Biosciences Business Overview
9.11.5 Castle Creek Biosciences Recent Developments
9.12 Sangamo Therapeutics
9.12.1 Sangamo Therapeutics Neurology Clinical Trial Basic Information
9.12.2 Sangamo Therapeutics Neurology Clinical Trial Product Overview
9.12.3 Sangamo Therapeutics Neurology Clinical Trial Product Market Performance
9.12.4 Sangamo Therapeutics Business Overview
9.12.5 Sangamo Therapeutics Recent Developments
9.13 Novartis
9.13.1 Novartis Neurology Clinical Trial Basic Information
9.13.2 Novartis Neurology Clinical Trial Product Overview
9.13.3 Novartis Neurology Clinical Trial Product Market Performance
9.13.4 Novartis Business Overview
9.13.5 Novartis Recent Developments
9.14 Holostem Terapie Avanzate S.R.L
9.14.1 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Basic Information
9.14.2 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product Overview
9.14.3 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product Market Performance
9.14.4 Holostem Terapie Avanzate S.R.L Business Overview
9.14.5 Holostem Terapie Avanzate S.R.L Recent Developments
9.15 Pharmicell
9.15.1 Pharmicell Neurology Clinical Trial Basic Information
9.15.2 Pharmicell Neurology Clinical Trial Product Overview
9.15.3 Pharmicell Neurology Clinical Trial Product Market Performance
9.15.4 Pharmicell Business Overview
9.15.5 Pharmicell Recent Developments
9.16 Tego Science
9.16.1 Tego Science Neurology Clinical Trial Basic Information
9.16.2 Tego Science Neurology Clinical Trial Product Overview
9.16.3 Tego Science Neurology Clinical Trial Product Market Performance
9.16.4 Tego Science Business Overview
9.16.5 Tego Science Recent Developments
9.17 Autolus therapeutics
9.17.1 Autolus therapeutics Neurology Clinical Trial Basic Information
9.17.2 Autolus therapeutics Neurology Clinical Trial Product Overview
9.17.3 Autolus therapeutics Neurology Clinical Trial Product Market Performance
9.17.4 Autolus therapeutics Business Overview
9.17.5 Autolus therapeutics Recent Developments
9.18 Bayer AG
9.18.1 Bayer AG Neurology Clinical Trial Basic Information
9.18.2 Bayer AG Neurology Clinical Trial Product Overview
9.18.3 Bayer AG Neurology Clinical Trial Product Market Performance
9.18.4 Bayer AG Business Overview
9.18.5 Bayer AG Recent Developments
9.19 Sartorius AG
9.19.1 Sartorius AG Neurology Clinical Trial Basic Information
9.19.2 Sartorius AG Neurology Clinical Trial Product Overview
9.19.3 Sartorius AG Neurology Clinical Trial Product Market Performance
9.19.4 Sartorius AG Business Overview
9.19.5 Sartorius AG Recent Developments
9.20 Daiichi Sankyo
9.20.1 Daiichi Sankyo Neurology Clinical Trial Basic Information
9.20.2 Daiichi Sankyo Neurology Clinical Trial Product Overview
9.20.3 Daiichi Sankyo Neurology Clinical Trial Product Market Performance
9.20.4 Daiichi Sankyo Business Overview
9.20.5 Daiichi Sankyo Recent Developments
9.21 Takeda Pharmaceutical Company
9.21.1 Takeda Pharmaceutical Company Neurology Clinical Trial Basic Information
9.21.2 Takeda Pharmaceutical Company Neurology Clinical Trial Product Overview
9.21.3 Takeda Pharmaceutical Company Neurology Clinical Trial Product Market Performance
9.21.4 Takeda Pharmaceutical Company Business Overview
9.21.5 Takeda Pharmaceutical Company Recent Developments
9.22 Sumitomo Chemical Co
9.22.1 Sumitomo Chemical Co Neurology Clinical Trial Basic Information
9.22.2 Sumitomo Chemical Co Neurology Clinical Trial Product Overview
9.22.3 Sumitomo Chemical Co Neurology Clinical Trial Product Market Performance
9.22.4 Sumitomo Chemical Co Business Overview
9.22.5 Sumitomo Chemical Co Recent Developments
10 Neurology Clinical Trial Market Forecast by Region
10.1 Global Neurology Clinical Trial Market Size Forecast
10.2 Global Neurology Clinical Trial Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurology Clinical Trial Market Size Forecast by Country
10.2.3 Asia Pacific Neurology Clinical Trial Market Size Forecast by Region
10.2.4 South America Neurology Clinical Trial Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurology Clinical Trial by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neurology Clinical Trial Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurology Clinical Trial by Type (2025-2030)
11.1.2 Global Neurology Clinical Trial Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurology Clinical Trial by Type (2025-2030)
11.2 Global Neurology Clinical Trial Market Forecast by Application (2025-2030)
11.2.1 Global Neurology Clinical Trial Sales (K Units) Forecast by Application
11.2.2 Global Neurology Clinical Trial Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings